Regeneron Pharmaceuticals Takes Over #42 Spot from Corteva in Analyst Rankings

Regeneron Pharmaceuticals has surpassed Corteva Inc in analyst rankings, taking the #42 spot in the S&P 500 study. This shift is based on the average analyst opinions from major brokerage houses. Analyst rankings can be interpreted differently, as a popular pick could mean the stock should perform well, but also highlights potential risks. The top and bottom ends of the lists can make for interesting stock picking ideas.